Association of serum uromodulin with death, cardiovascular events, and kidney failure in CKD
Background and objectives Uromodulin is exclusively produced by tubular epithelial cells and released into urine and serum. Higher serum uromodulin has been associated with lower risk for kidney failure in Chinese patients with CKD and with lower risk for mortality in the elderly and in patients und...
Saved in:
| Main Authors: | , , , , , , , , , , , , , |
|---|---|
| Format: | Article (Journal) |
| Language: | English |
| Published: |
May 7, 2020
|
| In: |
Clinical journal of the American Society of Nephrology
Year: 2020, Volume: 15, Issue: 5, Pages: 616-624 |
| ISSN: | 1555-905X |
| DOI: | 10.2215/CJN.11780919 |
| Online Access: | Verlag, lizenzpflichtig, Volltext: https://doi.org/10.2215/CJN.11780919 Verlag, lizenzpflichtig, Volltext: https://cjasn.asnjournals.org/content/15/5/616 |
| Author Notes: | Dominik Steubl, Markus P. Schneider, Heike Meiselbach, Jennifer Nadal, Matthias C. Schmid, Turgay Saritas, Vera Krane, Claudia Sommerer, Seema Baid-Agrawal, Jakob Voelkl, Fruzsina Kotsis, Anna Köttgen, Kai-Uwe Eckardt, Jürgen E. Scherberich, GCKD Study Investigators |
MARC
| LEADER | 00000caa a22000002c 4500 | ||
|---|---|---|---|
| 001 | 1753140293 | ||
| 003 | DE-627 | ||
| 005 | 20230426165440.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 210406s2020 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.2215/CJN.11780919 |2 doi | |
| 035 | |a (DE-627)1753140293 | ||
| 035 | |a (DE-599)KXP1753140293 | ||
| 035 | |a (OCoLC)1341403240 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Steubl, Dominik |d 1980- |e VerfasserIn |0 (DE-588)143676121 |0 (DE-627)654712409 |0 (DE-576)338896724 |4 aut | |
| 245 | 1 | 0 | |a Association of serum uromodulin with death, cardiovascular events, and kidney failure in CKD |c Dominik Steubl, Markus P. Schneider, Heike Meiselbach, Jennifer Nadal, Matthias C. Schmid, Turgay Saritas, Vera Krane, Claudia Sommerer, Seema Baid-Agrawal, Jakob Voelkl, Fruzsina Kotsis, Anna Köttgen, Kai-Uwe Eckardt, Jürgen E. Scherberich, GCKD Study Investigators |
| 264 | 1 | |c May 7, 2020 | |
| 300 | |a 9 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Gesehen am 06.04.2021 | ||
| 520 | |a Background and objectives Uromodulin is exclusively produced by tubular epithelial cells and released into urine and serum. Higher serum uromodulin has been associated with lower risk for kidney failure in Chinese patients with CKD and with lower risk for mortality in the elderly and in patients undergoing coronary angiography. We hypothesized that lower serum uromodulin is associated with mortality, cardiovascular events, and kidney failure in white patients with CKD. - Design, setting, participants, & measurements We measured serum uromodulin in 5143 participants enrolled in the German CKD (GCKD) study. The associations of baseline serum uromodulin with all-cause mortality, major adverse cardiovascular events (MACE; a composite of cardiovascular mortality, nonfatal myocardial infarction or stroke, or incident peripheral vascular disease), and kidney failure (dialysis or transplantation) were evaluated using multivariable Cox proportional hazard regression analyses in a cohort study design, adjusting for demographics, eGFR, albuminuria, cardiovascular risk factors, and medication. - Results The mean age of participants was 60±12 years, 60% were male. Mean serum uromodulin concentration was 98±60 ng/ml, eGFR was 49±18 ml/min per 1.73 m2, and 78% had eGFR <60 ml/min per 1.73 m2. Participants in lower serum uromodulin quartiles had lower eGFR and higher albuminuria, prevalence of diabetes, hypertension, coronary artery disease, and more frequent history of stroke at baseline. During a follow-up of 4 years, 335 participants died, 417 developed MACE, and 229 developed kidney failure. In multivariable analysis, the highest serum uromodulin quartile was associated with lower hazard for mortality (hazard ratio [HR], 0.57; 95% CI, 0.38 to 0.87), MACE (HR, 0.63; 95% CI, 0.45 to 0.90), and kidney failure (HR, 0.24; 95% CI, 0.10 to 0.55) compared with the lowest quartile. - Conclusions Higher serum uromodulin is independently associated with lower risk for mortality, cardiovascular events, and kidney failure in white patients with CKD. - Clinical Trial registry name and registration number Deutsches Register für Klinische Studien (DRKS; German national database of clinical studies), DRKS00003971. | ||
| 650 | 4 | |a albuminuria | |
| 650 | 4 | |a cardiovascular diseases | |
| 650 | 4 | |a chronic | |
| 650 | 4 | |a chronic kidney disease | |
| 650 | 4 | |a confidence intervals | |
| 650 | 4 | |a coronary angiography | |
| 650 | 4 | |a coronary artery disease | |
| 650 | 4 | |a diabetes mellitus | |
| 650 | 4 | |a end-stage renal disease | |
| 650 | 4 | |a epithelial cells | |
| 650 | 4 | |a glomerular filtration rate | |
| 650 | 4 | |a hypertension | |
| 650 | 4 | |a myocardial infarction | |
| 650 | 4 | |a peripheral vascular diseases | |
| 650 | 4 | |a regression analysis | |
| 650 | 4 | |a renal insufficiency | |
| 650 | 4 | |a risk factors | |
| 650 | 4 | |a stroke | |
| 650 | 4 | |a Tamm-Horsfall protein | |
| 650 | 4 | |a tubular function | |
| 650 | 4 | |a uromodulin | |
| 700 | 1 | |a Schneider, Markus P. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Meiselbach, Heike |e VerfasserIn |4 aut | |
| 700 | 1 | |a Nadal, Jennifer |e VerfasserIn |4 aut | |
| 700 | 1 | |a Schmid, Matthias C. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Saritas, Turgay |e VerfasserIn |4 aut | |
| 700 | 1 | |a Krane, Vera |e VerfasserIn |4 aut | |
| 700 | 1 | |a Sommerer, Claudia |d 1971- |e VerfasserIn |0 (DE-588)121857654 |0 (DE-627)705680002 |0 (DE-576)292921829 |4 aut | |
| 700 | 1 | |a Baid-Agrawal, Seema |e VerfasserIn |4 aut | |
| 700 | 1 | |a Voelkl, Jakob |e VerfasserIn |4 aut | |
| 700 | 1 | |a Kotsis, Fruzsina |e VerfasserIn |4 aut | |
| 700 | 1 | |a Köttgen, Anna |e VerfasserIn |4 aut | |
| 700 | 1 | |a Eckardt, Kai-Uwe |e VerfasserIn |4 aut | |
| 700 | 1 | |a Scherberich, Jürgen E. |e VerfasserIn |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |a American Society of Nephrology |t Clinical journal of the American Society of Nephrology |d Washington, DC : American Society of Nephrology, 2006 |g 15(2020), 5, Seite 616-624 |h Online-Ressource |w (DE-627)50595091X |w (DE-600)2216582-4 |w (DE-576)30683281X |x 1555-905X |7 nnas |
| 773 | 1 | 8 | |g volume:15 |g year:2020 |g number:5 |g pages:616-624 |g extent:9 |a Association of serum uromodulin with death, cardiovascular events, and kidney failure in CKD |
| 856 | 4 | 0 | |u https://doi.org/10.2215/CJN.11780919 |x Verlag |x Resolving-System |z lizenzpflichtig |3 Volltext |
| 856 | 4 | 0 | |u https://cjasn.asnjournals.org/content/15/5/616 |x Verlag |z lizenzpflichtig |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20210406 | ||
| 993 | |a Article | ||
| 994 | |a 2020 | ||
| 998 | |g 121857654 |a Sommerer, Claudia |m 121857654:Sommerer, Claudia |d 50000 |e 50000PS121857654 |k 0/50000/ |p 8 | ||
| 999 | |a KXP-PPN1753140293 |e 3902068787 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"name":{"displayForm":["Dominik Steubl, Markus P. Schneider, Heike Meiselbach, Jennifer Nadal, Matthias C. Schmid, Turgay Saritas, Vera Krane, Claudia Sommerer, Seema Baid-Agrawal, Jakob Voelkl, Fruzsina Kotsis, Anna Köttgen, Kai-Uwe Eckardt, Jürgen E. Scherberich, GCKD Study Investigators"]},"physDesc":[{"extent":"9 S."}],"recId":"1753140293","relHost":[{"corporate":[{"display":"American Society of Nephrology","role":"aut"}],"disp":"American Society of NephrologyClinical journal of the American Society of Nephrology","language":["eng"],"type":{"media":"Online-Ressource","bibl":"periodical"},"note":["Gesehen am 04.08.2025"],"origin":[{"publisherPlace":"Washington, DC","dateIssuedDisp":"2006-","dateIssuedKey":"2006","publisher":"American Society of Nephrology"}],"titleAlt":[{"title":"CJASN"}],"title":[{"subtitle":"CJASN","title_sort":"Clinical journal of the American Society of Nephrology","title":"Clinical journal of the American Society of Nephrology"}],"part":{"volume":"15","extent":"9","pages":"616-624","text":"15(2020), 5, Seite 616-624","year":"2020","issue":"5"},"pubHistory":["1.2006 -"],"recId":"50595091X","physDesc":[{"extent":"Online-Ressource"}],"id":{"eki":["50595091X"],"issn":["1555-905X"],"zdb":["2216582-4"]}}],"id":{"eki":["1753140293"],"doi":["10.2215/CJN.11780919"]},"person":[{"family":"Steubl","display":"Steubl, Dominik","given":"Dominik","role":"aut"},{"given":"Markus P.","role":"aut","display":"Schneider, Markus P.","family":"Schneider"},{"given":"Heike","role":"aut","display":"Meiselbach, Heike","family":"Meiselbach"},{"role":"aut","given":"Jennifer","family":"Nadal","display":"Nadal, Jennifer"},{"given":"Matthias C.","role":"aut","family":"Schmid","display":"Schmid, Matthias C."},{"given":"Turgay","role":"aut","family":"Saritas","display":"Saritas, Turgay"},{"role":"aut","given":"Vera","display":"Krane, Vera","family":"Krane"},{"display":"Sommerer, Claudia","family":"Sommerer","given":"Claudia","role":"aut"},{"family":"Baid-Agrawal","display":"Baid-Agrawal, Seema","role":"aut","given":"Seema"},{"given":"Jakob","role":"aut","display":"Voelkl, Jakob","family":"Voelkl"},{"given":"Fruzsina","role":"aut","display":"Kotsis, Fruzsina","family":"Kotsis"},{"display":"Köttgen, Anna","family":"Köttgen","given":"Anna","role":"aut"},{"family":"Eckardt","display":"Eckardt, Kai-Uwe","given":"Kai-Uwe","role":"aut"},{"family":"Scherberich","display":"Scherberich, Jürgen E.","given":"Jürgen E.","role":"aut"}],"note":["Gesehen am 06.04.2021"],"origin":[{"dateIssuedKey":"2020","dateIssuedDisp":"May 7, 2020"}],"type":{"bibl":"article-journal","media":"Online-Ressource"},"title":[{"title_sort":"Association of serum uromodulin with death, cardiovascular events, and kidney failure in CKD","title":"Association of serum uromodulin with death, cardiovascular events, and kidney failure in CKD"}],"language":["eng"]} | ||
| SRT | |a STEUBLDOMIASSOCIATIO7202 | ||